FBIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Fortress Biotech Inc (FBIO) is not a strong buy for a beginner investor with a long-term horizon at this time. The technical indicators show no clear upward momentum, options data reflects mixed sentiment, and the financial performance is weak despite revenue growth. Without positive catalysts or strong trading signals, holding off on investment is recommended.
The MACD is negative and expanding downward (-0.0422), indicating bearish momentum. RSI is neutral at 30.985. Moving averages are converging, showing no clear trend. Key support lies at 3.076, with resistance at 3.986. The stock's short-term trend suggests a 50% chance of a small gain (2.37%) in the next day, but longer-term trends are negative (-2% in the next month).
Revenue increased by 20.52% YoY in Q3 2025, which is a positive sign of growth.
Net income dropped significantly (-124.43% YoY), EPS declined (-114.47% YoY), and gross margin fell (-3.99% YoY). No recent news or significant insider or hedge fund activity. No recent congress trading data.
In Q3 2025, revenue grew to $17.63M (+20.52% YoY), but net income dropped to $3.68M (-124.43% YoY). EPS fell to 0.11 (-114.47% YoY), and gross margin declined to 61.32% (-3.99% YoY). While revenue growth is promising, profitability metrics are deteriorating.
No recent analyst rating or price target changes available for FBIO.
